vaccine manufacturers not view hurdle purely theoretical typically sars cov-2 earlier related coronavirus sars cov way cells docking site cell surface receptor called ace2 vaccines provide sought immunization neutralizing antibodies viral proteins blocking pathogen entrance ace2 portal antibody virus entering cells lab dish not necessarily mean behave way body says akiko iwasaki immunologist yale university scenarios describes recent antibodies occasionally help virus invade thwart immune cells normally engulf help clear pathogen antibodies produced not bind virus not present right concentration latch exacerbate disease process known antibody dependent enhancement ade ade antibody coated viruses gain backdoor entry antibody receptors macrophages members